Related Experiment Video

Updated: Feb 27, 2026

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice

Published on: April 15, 2014

84.1K

Is MOG-IgG another biomarker for neuromyelitis optica?

Ichiro Nakashima

    Journal of Neurology, Neurosurgery, and Psychiatry
    |July 8, 2017
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    NEUROIMMUNOLOGY

    More Related Videos

    Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
    05:55

    Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

    Published on: December 1, 2023

    1.4K
    Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
    10:47

    Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies

    Published on: October 27, 2016

    11.5K

    Related Experiment Videos

    Last Updated: Feb 27, 2026

    Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
    08:03

    Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice

    Published on: April 15, 2014

    84.1K
    Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
    05:55

    Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

    Published on: December 1, 2023

    1.4K
    Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
    10:47

    Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies

    Published on: October 27, 2016

    11.5K

    Related Concept Videos

    Myasthenia Gravis: Diagnostic Tests01:15

    Myasthenia Gravis: Diagnostic Tests

    2.8K
    Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
    The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
    2.8K

    Articles linked to this work by shared authors, journal, and citation graph.

    Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

    Neurology(R) neuroimmunology & neuroinflammation·2026

    Headache prevalence and types in multiple sclerosis and related neuroimmunological diseases: A multicenter study.

    Cephalalgia : an international journal of headache·2026

    Long-term effectiveness and safety of satralizumab for neuromyelitis optica spectrum disorder in a real-world clinical setting in Japan: A 2.5-year final analysis of a multicenter medical chart review (The SAkuraBeyond Study).

    Multiple sclerosis (Houndmills, Basingstoke, England)·2026

    Differences in the Neural Substrate for Physical and Mental Quality of Life in Patients With Multiple Sclerosis.

    Brain and behavior·2025

    Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 30‑Month Interim Analysis of Post‑marketing Surveillance.

    Neurology and therapy·2025

    Employment status of multiple sclerosis patients in Japan.

    Journal of medical economics·2024

    Epilepsy and education: a nationwide cohort study.

    Journal of neurology, neurosurgery, and psychiatry·2026

    Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

    Journal of neurology, neurosurgery, and psychiatry·2026

    Iatrogenic cerebral amyloid angiopathy: a scoping review.

    Journal of neurology, neurosurgery, and psychiatry·2026

    Associations of self-reported and objectively measured physical activity and amyotrophic lateral sclerosis risk.

    Journal of neurology, neurosurgery, and psychiatry·2026

    Cerebrospinal fluid haemoglobin as a monitoring biomarker for secondary brain injury after aneurysmal subarachnoid haemorrhage: prospective international multicentre validation study (HeMoVal).

    Journal of neurology, neurosurgery, and psychiatry·2026

    HLA-dependent association between EBNA1 antibody levels and disability progression in multiple sclerosis.

    Journal of neurology, neurosurgery, and psychiatry·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us